GlassScriptPhysician profile
Brad M Mallory
NPI 1417129982
$31,078.22
in general payments reported to CMS, 2019-2025
42 companies · $1,775 in 2025
The $1,775 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $7,206 · 2021: $2,517 · 2022: $1,153 · 2023: $1,800 · 2024: $1,874 · 2025: $1,775.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,449.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15,625.21 | 2019-2025 | |
| Abbvie INC. | $4,595.56 | 2019-2025 | |
| Amgen INC. | $1,367.73 | 2019-2025 | Repatha, Evenity, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,243.04 | 2019-2025 | Jardiance, Combivent Respimat, Spiriva Respimat |
| Lilly USA, LLC | $1,006.36 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $819.18 | 2019-2025 | Wegovy, Saxenda |
| Astrazeneca Pharmaceuticals LP | $723.25 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Merck Sharp & Dohme LLC | $630.61 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $622.59 | 2019-2025 | Xarelto, Spravato |
| Axsome Therapeutics, INC. | $531.36 | 2024-2025 | Auvelity |
| Mylan Specialty L.P. | $499.05 | 2022-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $389.64 | 2019-2025 | Trintellix |
| Amarin Pharma, INC. | $312.42 | 2019-2021 | |
| Astellas Pharma US INC | $305.57 | 2021-2024 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $287.80 | 2021-2025 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Mallory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.